Pulmonx
LUNG
$9.38
Share price
21.50%
Change (1 day)
-18.22%
Change (1 year)
Categories
Pulmonx (LUNG) - Cash on Hand
Cash on Hand as of December 2023 : $0.11 B
According to Pulmonx's latest financial reports the company has $0.11 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Pulmonx - Cash on Hand chart (from 2019 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $0.11 B | -17.03% |
| 2022-12-31 | $0.14 B | -21.61% |
| 2021-12-31 | $0.18 B | -22.25% |
| 2020-12-31 | $0.23 B | 716.88% |
| 2019-12-31 | $28.34 M | 587.37% |
| 2018-12-31 | $4.12 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Merit Medical MMSI | $0.58 B | 401.30% | 🇺🇸 USA |
 Inari Medical
NARI | $0.11 B | -1.41% | 🇺🇸 USA |